Cryoport and OCASA Align for Global Cold Chain Logistics Solutions
Cryoport, Inc. (OTCBB: CYRX) and OCASA, Inc. have entered into a master services agreement to provide global cold chain logistics solutions for life science and biotech commodities requiring cryogenic temperatures. OCASA will have access to Cryoport’s full range of cryogenic business solution capabilities including its proprietary Cryoport Express Shippers and cloud-based logistics management software platform, the Cryoportal.
Cryoport will leverage OCASA’s global logistics network to provide more complete global services to its customers. In conjunction with Cryoport and OCASA providing each other with logistics solutions, the Companies will engage in co-marketing, joint sales activities, and a wide range of customer-driven support requirements to provide comprehensive and seamless solutions to the life sciences and biotech industries.
Angel Guinea, Country Manager and Head of OCASA Logistics Solutions BioPharma Division, stated, “This alignment allows us to leverage Cryoport’s proven cold chain solutions across our global logistics footprint, and we are enthusiastic about the mutual value that will result.”
Cryoport’s CEO Jerrell Shelton stated, “We are delighted that we have this new partnership with OCASA. It is centered around our‘’powered by cryoport’ strategy and makes all of our solutions available to OCASA. OCASA has a particularly strong presence in certain geographies of interest and has already been providing reliable logistics services to some of our customers on a global basis. With this expanded relationship we will accelerate sales into these markets and further broaden the awareness of our solutions in the biotechnology and life sciences industries.”
OCASA (Organización Courier Argentina S.A.) is a global market leader in specialized international logistics with broad experience and specialization in the development of tailor-made logistics solutions. OCASA’s services include export, import/customs clearance, temperature controlled warehousing, secondary packaging and labeling, distribution, fulfillment, and general cold chain logistics for clinical trial investigational products, clinical trial samples/test kits, diagnostic specimens, commercial medications/vaccines, medical supplies/kits, controlled products, and dangerous infectious goods. For more information, visit www.ocasa.com/.
Cryoport provides leading edge frozen shipping logistics solutions to the biotechnology and life science industries through the combination of purpose built proprietary hardware and software technologies and skilled total turnkey management of the entire logistics process. Cryoport Express® liquid nitrogen dry vapor shippers are validated to maintain a constant -150°C temperature for a 10 plus day dynamic shipment duration, and its Cryoportal™ Logistics Management Platform manages the entire shipment process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport’s total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a “green” and environmentally friendly solution. Cryoport service options include recording the “chain of condition” and “chain of custody” for all shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes.26
